FDA Approves New Bristol-Myers Squibb Company Treatment for a Type of Late-Stage Skin Cancer

FDA Approves New Bristol-Myers Squibb Company Treatment for a Type of Late-Stage Skin Cancer: "

Melanoma patients lived longer with treatment

SILVER SPRING, Md., March 25, 2011 /PRNewswire-USNewswire/ --The U.S. Food and Drug Administration today approved Yervoy (ipilimumab) to treat patients with late-stage (metastatic) melanoma, the most dangerous type of skin cancer.

(Logo: <a href...

"